Edison Pharmaceutical Co. v. Food and Drug Administration, Department of Health, Education, and Welfare
Federal Reporter, 2d Series; 600: 831-843
Showing items related by title, author, creator and subject.
Department of Health, Education, and Welfare's Administration of Health Programs: Shortchanging Children. Subcommittee Print. 94th Congress, 2nd Session Unknown author (United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations, 1976)
Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs Letter From William J. Scanlon, Director, Health Financing and Public Health Issues to Rep. Thomas Bliley, Jr. and Rep. John D. Dingell on the U.S. Congress, House, Committee on Commerce and Rep. Fred Upton and Rep. Ron Klink on the U.S. Congress, House, Committee on Commerce, Subcommittee on Oversight and Investigations Scanlon, William J. (United States. General Accounting Office [GAO]. Health, Education and Human Services Division, 1999-02-26)
Department of Health and Human Services. Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients Letter and Attachment From Robert P. Murphy, General Counsel, United States General Accounting Office to Sen. James M. Jeffords and Sen. Edward M. Kennedy and Rep. Thomas J. Bliley, Jr. and Rep. John D. Dingell Murphy, Robert P. (United States. General Accounting Office [GAO], 1998-12-21)